西维斯健康CVS Health（CVS）2025年第三季度财报（10-Q）「NYSE」（英文版）（78页）.pdf

1、 _ _ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington,D.C.20549 FORM 10-Q (Mark One)QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURIT IES EXCHANGE ACT OF 1934 For the quarterly period ended September 30,2025 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURI TI

2、ES EXCHANGE ACT OF 1934 For the transition period fromtoCommission File Number:001-01011 CVS HEALTH CORPORATION(Exact name of registrant as specified in its charter)Delaware(State or other jurisdiction of incorporation or organization)One CVS Drive,Woonsocket,Rhode Island(Address of principal execut

3、ive offices)05-0494040(I.R.S.Employer Identification No.)02895(Zip Code)Registrants telephone number,including area code:(401)765-1500 Former name,former address and former fiscal year,if changed since last report:N/A Securities registered pursuant to Section 12(b)of the Act:Title of each class Comm

4、on Stock,par value$0.01 per share Trading Symbol(s)CVS Name of each exchange on which registered New York Stock Exchange Indicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934 during the preceding 12 mon

5、ths(or for such shorter period that the registrant was required to file such reports),and(2)has been subject to such filing requirements for the past 90 days.Yes No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuan

6、t to Rule 405 of Regulation S-T(232.405 of this chapter)during the preceding 12 months(or for such shorter period that the registrant was required to submit such files).Yes No Indicate by check mark whether the registrant is a large accelerated filer,an accelerated filer,a non-accelerated filer,a sm